Introduction and Aims: Bone and mineral disorders affect every patients with chronic kidney disease (CKD) and contribute to the burden of fractures and cardiovascular disease. Bone disorders have been associated with vascular calcification in CKD but the mechanisms underlying this bone-vessels axis anomalies are poorly understood. Vascular calcification is a tightly regulated process involving the transdifferentiation of vascular smooth muscle cells (VSMC) into "osteoblasts-like" cells. We hypothesized that during this process of transdifferentiation, VSMC will acquire an "osteocyte-like" phenotype. The aim of this study is to determine if calcified vessels from CKD rats express osteocytic markers. Methods: CKD is induced by 5/6 nephrectomy in Wistar rats and vascular calcification is induced by high calcium, phosphate and vitamin D supplementation. These rats were compared to CKD rats fed with a normal diet and control rats fed with either a normal diet or high calcium, phosphate and vitamin D supplementation. Thoracic aortas were harvested at sacrifices 4 weeks after 5/6 nephrectomy. The markers of vascular remodeling and osteogenic differentiation were analyzed by qPCR (RunX2, BMP-2, α-SMA) and immunofluorescence (osteocalcin) on thoracic aortas. The expression of sclerostin, dentin matrix acidic phosphoprotein-1 (DMP-1) and FGF-23 (osteocytic markers) in addition to Dickkopf related protein 1 (DKK1) were performed on the thoracic aortas by immunofluorescence and western-blot. Serum levels of sclerostin were determined at sacrifices.